Posted on Leave a comment

Fungal Pneumonia Market to Witness Growth by 2032, Estimates DelveInsight | Companies – Pfizer, Merck & Co., Gilead Sciences, Astellas Pharma, F2G Ltd, Cidara Therapeutics, Basilea Pharmaceutica

Fungal Pneumonia Market DelveInsight’s “Fungal Pneumonia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Fungal Pneumonia, historical and forecasted epidemiology as well as the Fungal Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. DelveInsight launched a new report on “Fungal Pneumonia Market […]

Posted on Leave a comment

Anemia In Chronic Kidney Disease Market to Witness Growth by 2032, Estimates DelveInsight | Companies – Sun Pharmaceutical Industries, Zydus Lifesciences

Anemia In Chronic Kidney Disease Market DelveInsight’s “Anemia In Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Anemia In Chronic Kidney Disease, historical and forecasted epidemiology as well as the Anemia In Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United […]

Posted on Leave a comment

B-Cell Lymphomas Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Oncternal, ZAI Lab, Pfizer, SystImmune, Vincerx, InnoCare

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 160+ key pharma and biotech companies are working on 170+ pipeline drugs in the B-Cell Lymphomas therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]

Posted on Leave a comment

Annuloplasty Rings Market to hit USD 46.32 Million by 2033, says We Market Research

The market for Annuloplasty Rings estimated at USD 32.56 Million in 2023, is projected to reach a revised size of USD 46.32 Million by 2033, growing at a CAGR of 4.1% over the analysis period 2022-2030. Annuloplasty Rings Market is projected to achieve a value of USD 32.56 Million in 2023, with a linear behavior […]

Posted on Leave a comment

Obesity Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Obesity pipeline constitutes 100+ key companies continuously working towards developing 130+ Obesity treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Obesity Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on Leave a comment

PD-1 Non-Small Cell Lung Cancer Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Genor Biopharma, Shandong Boan Biotech, Pfizer

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing 30+ PD-1 Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The PD-1 Non-Small Cell Lung Cancer Pipeline report […]

Posted on Leave a comment

Uveitis Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Active Biotech AB, Eyevensys, Alumis, Eli Lilly

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Uveitis pipeline constitutes 15+ key companies continuously working towards developing 15+ Uveitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Uveitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]

Posted on Leave a comment

Vutrisiran Market to Witness Growth by 2032, Estimates DelveInsight | Companies – Alnylam Pharmaceuticals, Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer, Ultragenyx Pharmaceutical

Vutrisiran Market DelveInsight’s “Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. DelveInsight launched a new report on “Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032“. […]

Posted on Leave a comment

Gorlin Syndrome Market to Witness Growth by 2032, Estimates DelveInsight | Companies – LEO Pharma A/S, Mayne Pharma Group Limited, PellePharm

Gorlin Syndrome Market DelveInsight’s “Gorlin Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Gorlin Syndrome, historical and forecasted epidemiology as well as the Gorlin Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. DelveInsight launched a new report on “Gorlin Syndrome Market […]

Posted on Leave a comment

Neuroendocrine Tumors Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Panavance Therapeutics, Nano Pharma, Oxford BioTherapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 55+ key companies continuously working towards developing 60+ Neuroendocrine Tumors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Neuroendocrine Tumors Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]